Luminex Corporation_Amnis_ISEVxTech_DATA.zip

<strong>ISEVxTech rEV Characterization Study</strong> The purpose of the study is to highlight the utility that each assay/platform can provide for the research community and demonstrate what is achievable by the manufacturer. It is clear from the EV literature that orthogonal measurements of EVs is recommended and it is our aim to demonstrate the concordance and utility of data acquired from different platforms that work in complementary ways. Simultaneously, the organizers are aiming to promote reporting transparency, along with standard data analysis and reporting. This study will kick-start an open ISEV Task Force standardization study, with the sponsor company data setting a benchmark for their platforms / assays. <strong>This data was acquired in CellStream and ImageStream imaging flow cytometry systems using recombinant GFP-EVs.</strong> <strong>Copyright 2022 Luminex Corporation, a DiaSorin Company. For research use only. </strong>